References
- ScottDLSymmonsDPCoultonBLPopertAJLong-term outcome of treating rheumatoid arthritis: results after 20 yearsLancet198718542110811112883443
- MitchellDMSpitzPWYoungDYBlochDAMcShaneDJFriesJFSurvival, prognosis, and causes of death in rheumatoid arthritisArthritis Rheum19862967067143718563
- PincusTCallahanLFSaleWGBrooksALPayneLEVaughnWKSevere functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine yearsArthritis Rheum19842788648726431998
- IsomäkiHLong-term outcome of rheumatoid arthritisScand J Rheumatol Suppl199295381475632
- WolfeFThe natural history of rheumatoid arthritisJ Rheumatol Suppl19964413228833046
- FiresteinGSEvolving concepts of rheumatoid arthritisNature2003423693735636112748655
- SmolenJSAletahaDKoellerMWeismanMHEmeryPNew therapies for treatment of rheumatoid arthritisLancet200737096021861187417570481
- RadnerHNeogiTSmolenJSAletahaDPerformance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature reviewAnn Rheum Dis201473111412323592710
- RainsfordKDParkeALClifford-RashotteMKeanWFTherapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseasesInflammopharmacology201523523126926246395
- MahonGJAndersonHRGardinerTAMcFarlaneSArcherDBStittAWChloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathyCurr Eye Res200428427728415259297
- RütherKFoersterJBerndtSSchroeterJChloroquine/hydroxychloroquine: variability of retinotoxic cumulative dosesOphthalmologe200710410875879 German17653725
- MarmorMFKellnerULaiTYMellesRBMielerWFAmerican Academy of OphthalmologyRecommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision)Ophthalmology201612361386139426992838
- TsangACAhmadi PirshahidSVirgiliGGottliebCCHamiltonJCouplandSGHydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening testOphthalmology201512261239125125824328
- HoodDCBachMBrigellMISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition)Doc Ophthalmol20121241113
- BernsteinHNOcular safety of hydroxychloroquineAnn Ophthalmol19912382922961952638
- BrowningDJHydroxychloroquine and chloroquine retinopathy: screening for drug toxicityAm J Ophthalmol2002133564965611992862
- MarmorMFCarrREEasterbrookMFarjoAAMielerWFAmerican Academy of OphthalmologyRecommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of OphthalmologyOphthalmology200210971377138212093666
- BernsteinHNGinsbergJThe pathology of chloroquine retinopathyArch Ophthalmol19647123824514089397
- WrightCISabineJCCholinesterases of human erythrocytes and plasma and their inhibition by antimalarial drugsJ Pharmacol Exp Ther194893223023918865209
- RainesMFBhargavaSKRosenESThe blood-retinal barrier in chloroquine retinopathyInvest Ophthalmol Vis Sci1989308172617312759787
- KorthagenNMBastiaansJvan MeursJCvan BilsenKvan HagenPMDikWAChloroquine and hydroxychloroquine increase retinal pigment epithelial layer permeabilityJ Biochem Mol Toxicol201529729930425752684
- AbeTSuganoESaigoYTamaiMInterleukin-1beta and barrier function of retinal pigment epithelial cells (ARPE-19): aberrant expression of junctional complex moleculesInvest Ophthalmol Vis Sci20034494097410412939333
- YoshikawaTOgataNIzutaHShimazawaMHaraHTakahashiKIncreased expression of tight junctions in ARPE-19 cells under endoplasmic reticulum stressCurr Eye Res201136121153116321978097
- MoschosMMNitodaEChatziralliIPGatzioufasZKoutsandreaCKitsosGAssessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography studyDrug Des Devel Ther2015929932999
- SoSCHedgesTRSchumanJSQuirezaMLEvaluation of hydroxychloroquine retinopathy with multifocal electroretinographyOphthalmic Surg Lasers Imaging200334325125812757106
- MoschosMNMoschosMMApostolopoulosMMalliasJABourosCTheodossiadisGPAssessing hydroxychloroquine toxicity by the multifocal ERGDoc Ophthalmol20041081475315104166
- MaturiRKYuMWeleberRGMultifocal electroretinographic evaluation of long-term hydroxychloroquine usersArch Ophthalmol2004122797398115249360
- LaiTYChanWMLiHLaiRYLamDSMultifocal electroretinographic changes in patients receiving hydroxychloroquine therapyAm J Ophthalmol2005140579480716310457
- AliferisKMermoudCSafranABMultifocal electroretinography in follow-up of patients treated with hydroxychloroquineJ Fr Ophtalmol2011347468475 French21549445
- KellnerURennerABTillackHFundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquineInvest Ophthalmol Vis Sci20064783531353816877425
- CelliniMVersuraPLeonettiPOcular surface and intraocular inflammation are related in SS-I and rheumatoid arthritis patientsRheumatol Int200727985385717297622
- TreseMLiYGaoHQiaoXInflammation exacerbates hydroxychloroquine-induced retinotoxicity in human retinal pigment epithelial cellsInvest Ophthalmol Vis Sci2013546090
- PacheMSchwarzHAKaiserHJElevated plasma endothelin- 1 levels and vascular dysregulation in patients with rheumatoid arthritisMed Sci Monit200289CR616CR61912218941
- MiyakeYFocal macular electroretinographyNagoya J Med Sci1998613–479849879190